戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  a tumor suppressor gene mutated in cases of hereditary breast and ovarian cancer.
2 ift deletion in the BRCA1 gene implicated in hereditary breast and ovarian cancer.
3 type to BRCA2 mutations found in humans with hereditary breast and ovarian cancer.
4 tifunctional protein that is mutated in many hereditary breast and ovarian cancers.
5 CA1, account for a significant proportion of hereditary breast and ovarian cancers.
6 pected hereditary PCA, BRCA1/2 for suspected hereditary breast and ovarian cancer, and DNA mismatch r
7          The FANCJ DNA helicase is linked to hereditary breast and ovarian cancers as well as bone ma
8 reen the entire 5.53 kb coding region of the hereditary breast and ovarian cancer BRCA1 gene for all
9 nd female members of BRCA1- and BRCA2-linked hereditary breast and ovarian cancer families, who were
10 s in BRCA1 or BRCA2 may entirely account for hereditary breast and ovarian cancer families.
11 n-cyclin-dependent kinase complexes; and the hereditary breast and ovarian cancer gene (BRCA1).
12 ional analysis of the 3.43 kb exon 11 of the hereditary breast and ovarian cancer gene BRCA1 .
13 ns in the 3.45-kilobases (kb) exon 11 of the hereditary breast and ovarian cancer gene BRCA1.
14                                          The hereditary breast and ovarian cancer gene, BRCA1, encode
15                Much of the predisposition to hereditary breast and ovarian cancer has been attributed
16 east cancer and almost all cases of combined hereditary breast and ovarian cancer, has been implicate
17 sposition genes that result in a syndrome of hereditary breast and ovarian cancer (HBOC).
18 history of breast or ovarian cancer or both [hereditary breast and ovarian cancer (HBOC)].
19 ic lethality to target DNA repair defects in hereditary breast and ovarian cancer.In recent clinical
20 between the BRCA1 tumour-suppressor gene and hereditary breast and ovarian cancer is established, the
21           We identified a BRCA1 carrier in a hereditary breast and ovarian cancer kindred who develop
22 h MSH6 and PMS2 mutations may present with a hereditary breast and ovarian cancer phenotype.
23  Cells mutated for the genes involved in the hereditary breast and ovarian cancer susceptibility synd
24 n case-control studies, and OC patients with hereditary breast and ovarian cancer syndrome (HBOC) as
25                                              Hereditary breast and ovarian cancer syndrome (HBOC) is
26                                              Hereditary breast and ovarian cancer syndrome carries si
27 s, hereditary nonpolyposis colon cancer, and hereditary breast and ovarian cancer syndromes are prima
28                                              Hereditary breast and ovarian cancer syndromes can be ca
29          As a result of intensive studies on hereditary breast and ovarian cancers, two breast cancer
30          Loss or mutation is associated with hereditary breast and ovarian cancers, whereas altered e

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。